FAST
61
-3
WAT
60
-5
KO
42
-2
AIG
44
-3
NDAQ
59
-4
CRM
69
-6
FLR
50
2
GT
60
-2
DGX
39
-9
NUE
53
-5
WM
80
-5
DE
39
3
ORCL
68
-3
QRVO
6
2
HP
37
-8
XOM
48
-3
ILMN
42
-3
SRE
63
-3
TEL
69
-5
ORLY
66
-3
FAST
61
-3
WAT
60
-5
KO
42
-2
AIG
44
-3
NDAQ
59
-4
CRM
69
-6
FLR
50
2
GT
60
-2
DGX
39
-9
NUE
53
-5
WM
80
-5
DE
39
3
ORCL
68
-3
QRVO
6
2
HP
37
-8
XOM
48
-3
ILMN
42
-3
SRE
63
-3
TEL
69
-5
ORLY
66
-3
Financhill
Back

Sophia Genetics SA 10K Form

Buy
70

SOPH
Sophia Genetics SA

Last Price:
3.52
Seasonality Move:
9.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SOPH News And Ratings

See the #1 stock for the next 7 days that we like better than SOPH

SOPH Financial Statistics

Sales & Book Value

Annual Sales: $62.37M
Cash Flow: $-10.7M
Price / Cash Flow: 0
Annual Sales: $1.71
Price / Book: 2.17

Profitability

EPS (TTM): -1.09000
Net Income (TTM): $-71.4M
Gross Margin: $42.91M
Return on Equity: -52.73%
Return on Assets: -37.54%

Sophia Genetics SA Earnings Forecast

Key Sophia Genetics SA Financial Ratios

  • The Gross Profit Margin over the past 5 years for SOPH is 68.80%.
  • The Selling, General & Administrative Expenses for SOPH have been equal to 131.03% of Gross Profit Margin.
  • The Research & Development expenses have been 59.27% of Revenue.
  • The Interest Expense is -0.74% of Operating Income.
  • The Net Earning history of SOPH is -126.63% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

Sophia Genetics SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Technology
Sector: Health Care
Current Symbol: SOPH
Website: sophiagenetics.com

Debt

Debt-to-Equity Ratio: 0.12
Current Ratio: 3.8
Quick Ratio: 3.42

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SOPH Technical Analysis vs Fundamental Analysis

Buy
70
Sophia Genetics SA (SOPH) is a Buy

Is Sophia Genetics SA a Buy or a Sell?